title: Antimicrobial innovation: combining commitment, creativity and coherence.
abstract: Enhanced antibiotic innovation depends on many things--defining and validating new and better targets, resourcing and facilitating high-quality preclinical and clinical research, streamlining regulation and solving market problems so as to provide incentives to the private sector. Further detail is provided in our recent report (see further information). Acting on these critical steps in concert to provide long-term solutions requires that urgent attention be paid to tackling policy disconnects. Sustaining the political commitment depends on raising the visibility of the problems and their solutions worldwide. The academies of science in the EU recognize their continuing responsibility to help do this.
authors.affiliation: Emeritus Professor of Medicine at Radboud University Medical Centre, PO Box 9101, 6500HB Nijmegen, The Netherlands, and President of EASAC.
authors.forename: Jos W M
authors.initials: JW
authors.lastname: van der Meer
authors.affiliation: German National Academy of Sciences Leopoldina, Jägerberg 1, 06019 Halle (Saale), Germany, and Scientific Secretary of the Biosciences Programme at EASAC.
authors.forename: Robin
authors.initials: R
authors.lastname: Fears
authors.affiliation: Department of Health, Richmond House, 76 Whitehall, London, SW1A 2NS UK.
authors.forename: Sally C
authors.initials: SC
authors.lastname: Davies
authors.affiliation: Julius-Maximilians-Universität Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany, Chair of the Biosciences Programme at EASAC and Co-Chair of the InterAcademy Partnership.
authors.forename: Volker
authors.initials: V
authors.lastname: ter Meulen
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D015195:Drug Design; D004352:Drug Resistance, Microbial; D006801:Humans; D011050:Policy Making
chemical_list: D000890:Anti-Infective Agents